News - Ani Bookmark

mRNA structure modification

Bellasmith121 Dec, 2022News

During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method.

what is RNA fluorescence assay

Bellasmith121 Dec, 2022News

lyophilized yfgh antibody

Bellasmith121 Dec, 2022News

Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and microorganisms, focusing on the research needs of different models of biological antibodies and becoming a direct supplier of products.

microfluidics based point-of-care diagnostics

Bellasmith121 Dec, 2022News

Point-of-care technology (POCT) diagnostic systems are tools that can rapidly lead to in vitro diagnostic (IVD) results by non-trained personnel at a patient site in varieties of locations such as the field, the home, the ambulance, or the hospital. To this day, diagnostic tests are typically operated at laboratories equipped with bench-top analyzers and managed by trained personnel. That is to say, there have been a few days to wait before patients receive their testing results.

microfluidic protein detection

Bellasmith121 Dec, 2022News

As a leading service provider in the field of microfluidic systems, Creative Biolabs has launched an integrated platform for the development of a wide range of rapid and sensitive microfluidic chips to achieve protein digestion, identification, and analysis using electrospray ionization mass spectrometry (ESI-MS) or many other mass spectrometry (MS) detections.

Next Generation Probiotics Services for Autism Spectrum Disorder (ASD)

Bellasmith121 Dec, 2022News

With the growing research on probiotics and the integral part, they play in the health of the gastric intestinal (GI) tract and the whole body, their inclusions as an integrative treatment may be of great use for children with ASD. Creative Biolabs provides a series of next-generation probiotics (NGPs) discovery and analysis services characterized by quality, predictability, delivery, and customization. Our employees have the operational courage and scientific background that you need for your success.

Football Transfer News, Live Updates: Chelsea approach Man United's Garnacho

Sportsliveresults21 Dec, 2022News

Premier League giants have showed their interest in Manchester United wonderkid Garnacho and Juventus midfielder Weston McKennie. Reportedly, Barcelona forward Memphis Depay, defenders Hector Bellerin, Franck Kessie, Jordi Alba and captain Sergio Busquets are likely to move to a new club in January. While Depay,

cga antibody

Bellasmith121 Dec, 2022News

Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, our scientists are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Our services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numerous details. Our dedicated scientists are able to undertake the entire discovery pipeline but also pleased to offer specific service based on clients’ requirements. Creative Biolabs is adhering the customer first and goal-oriented concept to serve our global clients with the most reliable and qualified results.

PD-L1 Antibody Optimization

Bellasmith121 Dec, 2022News

Creative Biolabs provides a full range of immune checkpoint antibody development services from antibody discovery to preclinical trials in a timely and cost-effective manner. Our featured services include monoclonal antibody development, phage display antibody library construction and screening, antibody humanization, antibody production, bispecific antibody development, and so on. Besides, we also support immune checkpoint small molecule drug development and immune checkpoint assays to meet your specific requirement. Moreover, we also provide a series of high-quality immune checkpoint-related products to support your immune checkpoint research and drug discovery projects.

KCTD2 pU6 shRNA

Bellasmith121 Dec, 2022News

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow treating a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery. There are numerous ongoing researches of which the focus is testing several approaches to gene therapy. Although gene therapy is a promising treatment scenario for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections, there is still a number of obstacles to be overcome in terms of the therapeutic modality selection and design at the very early stage of development, design and application of in vitro and in vivo assays for proof-of-concept studies, comprehensive development of full set of assays for measuring potency and safety, from which the information should be clarified to support an Investigational New Drug Application (IND) or a Biologics License Application (BLA).